Results · Apr-Jun 2026 · filed 12 Aug 2026
India Glycols Q1 FY27 results
Sales grew 19% to ₹2,988 crore from ₹2,503 crore in Apr-Jun 2025.
Operating profit grew 13% to ₹170 crore, an operating margin of 5.7% (down 0.3 points from a year ago).
Net profit grew 32% to ₹96.8 crore from ₹73.3 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +27%, net profit +11%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 2,988 | 2,503 | +19% |
| Operating profit (EBITDA) | 169.6 | 149.6 | +13% |
| Operating margin | 5.7% | 6.0% | −0.3 pts |
| Net profit | 96.8 | 73.3 | +32% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 13 Aug 2026Reminder For Mandatory Furnishing Of PAN, KYC Details And Nomination For Holders Of Physical Securities.
- 12 Aug 2026Board Meeting Outcome for Outcome Of The Board Meeting
- 12 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 12 Aug 2026Financial Results
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.